Isomark
Emeritus biochemist from UW-Madison with 25 years of research expertise in metabolism, stable isotopes, breath studies, metabolomics and protein chemistry through NIH, NSF and private funded programs. As a PI or Co-PI, Dr. Assadi-Porter brought more than $14 million in research funds over the past ten years in high impact, high risks competitions. She has 15 years of entrepreneurial and business experience, and business certification programs through D2P and UP-Start entrepreneurial programs at UW-Madison and School of Business.
This person is not in any offices
Isomark
Isomark is a developer of infectious disease detection technologies for healthcare providers.